{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:45:37Z","timestamp":1791909937247,"version":"4.3.4"},"reference-count":85,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"34","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:p> Mesothelin is a tumor antigen that is highly expressed in many human cancers, including malignant mesothelioma and pancreatic, ovarian, and lung adenocarcinomas. It is an attractive target for cancer immunotherapy because its normal expression is limited to mesothelial cells, which are dispensable. Several antibody-based therapeutic agents as well as vaccine and T-cell therapies directed at mesothelin are undergoing clinical evaluation. These include antimesothelin immunotoxins (SS1P, RG7787\/LMB-100), chimeric antimesothelin antibody (amatuximab), mesothelin-directed antibody drug conjugates (anetumab ravtansine, DMOT4039A, BMS-986148), live attenuated Listeria monocytogenes\u2013expressing mesothelin (CRS-207, JNJ-64041757), and chimeric antigen receptor T-cell therapies. Two antimesothelin agents are currently in multicenter clinical registration trials for malignant mesothelioma: amatuximab in the first-line setting and anetumab ravtansine as second-line therapy. Phase II randomized clinical trials of CRS-207 as a boosting agent and in combination with immune checkpoint inhibition for pancreatic cancer are nearing completion. These ongoing studies will define the utility of mesothelin immunotherapy for treating cancer. <\/jats:p>","DOI":"10.1200\/jco.2016.68.3672","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T17:24:06Z","timestamp":1476206646000},"page":"4171-4179","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":301,"title":["Mesothelin Immunotherapy for Cancer: Ready for Prime Time?"],"prefix":"10.1200","volume":"34","author":[{"given":"Raffit","family":"Hassan","sequence":"first","affiliation":[{"name":"Raffit Hassan, Anish Thomas, Christine Alewine, and Ira Pastan, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda; and Dung T. Le and Elizabeth M. Jaffee, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Thomas","sequence":"additional","affiliation":[{"name":"Raffit Hassan, Anish Thomas, Christine Alewine, and Ira Pastan, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda; and Dung T. Le and Elizabeth M. Jaffee, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Alewine","sequence":"additional","affiliation":[{"name":"Raffit Hassan, Anish Thomas, Christine Alewine, and Ira Pastan, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda; and Dung T. Le and Elizabeth M. Jaffee, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung T.","family":"Le","sequence":"additional","affiliation":[{"name":"Raffit Hassan, Anish Thomas, Christine Alewine, and Ira Pastan, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda; and Dung T. Le and Elizabeth M. Jaffee, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Jaffee","sequence":"additional","affiliation":[{"name":"Raffit Hassan, Anish Thomas, Christine Alewine, and Ira Pastan, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda; and Dung T. Le and Elizabeth M. Jaffee, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Pastan","sequence":"additional","affiliation":[{"name":"Raffit Hassan, Anish Thomas, Christine Alewine, and Ira Pastan, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda; and Dung T. Le and Elizabeth M. Jaffee, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500308"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.1.136"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200311000-00003"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199203000-00006"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/01.pai.00000141545.36485.d6"},{"key":"B6","first-page":"3862","volume":"7","author":"Argani P","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1309\/F1B64CL7H8VJKEAF"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3429"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114900"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00928.x"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<559::AID-IJC13>3.0.CO;2-Y"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2883"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1272"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0337"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0869"},{"key":"B17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0021-9258(17)42180-6","volume":"269","author":"Yamaguchi N","year":"1994","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0466"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.082515999"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6807-9-1"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1107\/S1744309112028229"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.8.2902-2906.2000"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02279.x"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02080.x"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200302000-00002"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000056981.16578.C3"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.03.002"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000292"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0487-T"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(03)00177-1"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2003.10.012"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2012.02214.x"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1397"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604964"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2161"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2008.06.006"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/jso.22024"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.235"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2803"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1662"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.9738\/INTSURG-D-13-00001.1"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1309\/37RTWYAEPABYY410"},{"key":"B44","first-page":"63","volume":"31","author":"Obulhasim G","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3077-5"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2018-4"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312372200"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-50"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-07-0254"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2614"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/srep01870"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20110282"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgr075"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-106"},{"key":"B55","first-page":"4158","volume":"63","author":"Sato N","year":"2003","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0474"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.193458"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3776"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.2.669"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/9872"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1891"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0062"},{"key":"B63","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/cncr.28875","volume":"120","author":"Hassan R","year":"2014","journal-title":"Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006941"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1623"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0089-T"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0132"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209292109"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.1.145"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031435"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0406035101"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2121"},{"key":"B73","first-page":"20","volume":"7","author":"Hassan R","year":"2007","journal-title":"Cancer Immun"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2275"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0926"},{"key":"B76","unstructured":"Hassan R, Blumenschein G Jr, Kindler HL, et al: Phase I study of anti-mesothelin antibody drug conjugate anetumab ravtansine. Presented at the 16th World Conference on Lung Cancer, Denver, CO, September 6-9, 2015"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0693"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0583"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2217\/imt.16.4"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0170"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010162"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1160-3"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0493"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0804"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-2984-z"},{"key":"B86","doi-asserted-by":"crossref","unstructured":"Hassan R, Antonia S, Alley E, et al: Anti-mesothelin vaccine CRS-207 plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM). Presented at the European Cancer Congress, Vienna, Austria, September 25-29, 2015","DOI":"10.1186\/2051-1426-3-S2-P161"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.4244"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2016.68.3672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T08:22:41Z","timestamp":1653812561000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2016.68.3672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":85,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2016,12,1]]}},"alternative-id":["10.1200\/JCO.2016.68.3672"],"URL":"https:\/\/doi.org\/10.1200\/jco.2016.68.3672","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]},"assertion":[{"value":"2016-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}